English | Español
Press release submission | Dec 29, 2021

NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies

Press release submission | Dec 29, 2021

Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Press release submission | Dec 29, 2021

Hansa Biopharma enrolls first patient in U.S. randomized, controlled pivotal trial of imlifidase in highly sensitized kidney transplant patients

Press release submission | Dec 28, 2021

Quidel’s Antigen Tests Detect the Omicron Variant

Press release submission | Dec 28, 2021

Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease

Bree Gonzales | Dec 28, 2021

'With omicron on the rise,' California health care workers mandated to get COVID-19 booster shots
Bree Gonzales | Dec 27, 2021

Hochul signs legislation to 'expand access to health care and enhance services for all New Yorkers'
Bree Gonzales | Dec 27, 2021

Oracle buys Cerner in a $28 billion deal: 'It's a smart move by Oracle'

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval